Insider · CIK 0001726049
Avnur Zafrira
Reports to the SEC for 1 company · WALTHAM, MA
Transactions
7
Companies
1
Filings
7
CIK
0001726049
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-06-15 | ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award | — |
| 2021-05-19 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-05-20 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2019-05-29 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-06-15 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2018-03-26 | ELOXEloxx Pharmaceuticals, Inc.P Purchase | +$19K |
| 2018-03-21 | ELOXEloxx Pharmaceuticals, Inc.P Purchase | +$1,998.8 |
Recent filings
- 4Avnur Zafrira0001104659-22-072175SEC(opens sec.gov)
- 4Avnur Zafrira0001415889-21-002613SEC(opens sec.gov)
- 4Avnur Zafrira0001415889-20-001301SEC(opens sec.gov)
- 4Avnur Zafrira0001415889-19-000625SEC(opens sec.gov)
- 4Avnur Zafrira0001209191-18-038717SEC(opens sec.gov)
- 4Avnur Zafrira0001209191-18-021928SEC(opens sec.gov)
- 4Avnur Zafrira0001209191-18-021336SEC(opens sec.gov)
Companies
Address
C/O ELOXX PHARMACEUTICALS, INC. 950 WINTER STREET, 4TH FLOOR NORTH
WALTHAM, MA, 02451